Zeev Russak is a founder and CEO with hands‐on bio‐convergence experience,

integrating AI, software engineering, and molecular biology to improve healthcare. At

Infiniplex, he leads the development of clinician‐ready cancer treatment monitoring

technologies that unite scientific and engineering approaches. His work spans

algorithm validation scaled data systems, and cross‐functional collaboration across

research, engineering, and clinical teams. He has raised over $7M to advance the

company’s mission and growth. Previously, he held technical leadership, product, and

advisory roles across diagnostics and imaging initiatives. Zeev is an inventor on 20+

patents, reflecting sustained innovation at the biology–computation interface. He is

pursuing formal CEO training to deepen organization design, growth execution, and

evidence‐based decision‐making while scaling product‐centric, clinically impactful

solutions